OptiBiotix Health (LON:OPTI) Hits New 12-Month Low – Should You Sell?

OptiBiotix Health Plc (LON:OPTI)’s share price hit a new 52-week low during trading on Thursday . The company traded as low as GBX 7.50 and last traded at GBX 7.90, with a volume of 57448 shares trading hands. The stock had previously closed at GBX 7.75.

OptiBiotix Health Trading Up 1.9%

The firm has a market capitalization of £8.16 million, a P/E ratio of -263.33 and a beta of 1.71. The business has a 50-day moving average of GBX 9.86 and a 200 day moving average of GBX 12.31.

OptiBiotix Health (LON:OPTI) last issued its earnings results on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.

Insider Buying and Selling

In related news, insider Stephen O’Hara bought 95,238 shares of the company’s stock in a transaction dated Tuesday, September 23rd. The shares were bought at an average price of GBX 11 per share, for a total transaction of £10,476.18. Also, insider David Blain bought 84,053 shares of the business’s stock in a transaction that occurred on Wednesday, October 1st. The shares were bought at an average cost of GBX 1,175 per share, for a total transaction of £987,622.75. Insiders have acquired a total of 229,291 shares of company stock valued at $100,309,893 over the last three months. Corporate insiders own 26.82% of the company’s stock.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.